Leuprolide Completed Phase 4 Trials for Puberty, Precocious Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02427958A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants